| |
| |
SPOT ON
|
| |
Systematic reviews: always the best evidence?
|
| |
| |
THERAPY FROM A CRITICAL VIEWPOINT
|
| |
Meningococcal C vaccination for all one years old kids?
|
| |
| |
REVIEW
|
| |
Clopidogrel (ISCOVER, PLAVIX):
For whom? How much? How long?
|
| |
| |
ORIGINAL ARTICLE
|
| |
KOCHEN, M.N., NIEBLING, W.: Proton pump inhibitors - Information for a rational use in general practice
|
| |
| |
BEWARE MISINFORMATION
|
| |
Rimonabant (ACOMPLIA): Advice of Sanofi-Aventis for its sales force
|
| |
| |
a-t READERS' QUESTIONS AND COMMENTS
|
| |
Statutory Healthcare: sales discounts for insulin analogues
|
| |
| |
IN BRIEF
|
| |
ALZHEIMER-disease: "atypical" neuroleptics not better than placebo
|
 |
Cholinesterase-inhibitors: preliminary report of "IQWiG"
|
| |
Aprotinin (TRASYLOL) and Bayer's less of memory
|
| |
| |
CURRENT ADR NETWORK REPORT
|
| |
Topiramat for migraine (TOPAMAX MIGRAENE): risk of serious psychological side effects
|
| |